Este sitio web estará fuera de servicio el próximo miércoles 18/Sep. de las 14:00 a 17:00 hrs. por trabajos de mantenimiento.
Osmel Fleitas Martínez
Investigador Posdoctoral DGAPA
Total de publicaciones: 16
- Tipo
- Fecha
Artículo
1 - de Souza,C.M., Oliveira,O.W.S., Fleitas-Martinez O., Dos Santos Neto,N.A., Buccini,D.F., Nieto-Marin,V., de Faria Junior,C., Rocha,M.M., Soller Ramada,M.H., Franco,O.L. (2024). Evaluating virulence features of Acinetobacter baumannii resistant to polymyxin B.
Letters in Applied Microbiology,
77 (7),
ovae061.
*
Artículo
2 - Fleitas,O., Fontes,W., de Souza,C.M., Da Costa,M.C., Cardoso,M.H., Castro,M.S., Sousa,M.V., Ricart,C.A.O., Ramada,M.H.S., Duque,H.M., Porto,W.F., Silva,O.N., Franco,O.L. (2024). A proteomic perspective on the resistance response of Klebsiella pneumoniae to antimicrobial peptide PaDBS1R1.
Journal of Antimicrobial Chemotherapy,
79 (1),
112-122.
*
Artículo
3 - de Souza,C.M., Martinez,O.F., Duque,H.M., Franco,O.L. (2023). Expanding therapeutic potential of Bdellovibrio bacteriovorus against multidrug-resistant pathogens.
Drug Discovery Today,
28 (6),
103595.
*
Revisión
4 - de Souza,C.M., da Silva,A.P., Junior,N.G.O., Martinez,O.F., Franco,O.L. (2022). Peptides as a therapeutic strategy against Klebsiella pneumoniae.
Trends in Pharmacological Sciences,
43 (4),
335-348.
*
Revisión
5 - de Souza,C.M., da Silva,A.P., Oliveira,N.G., Martinez,O.F., Franco,O.L. (2022). Peptides as a therapeutic strategy against Klebsiela pneumoniae.
Trends in Pharmacological Sciences,
43 (4),
335-348.
*
Revisión
6 - Martinez,O.F., Duque,H.M., Franco,O.L. (2022). Peptidomimetics as Potential Anti-Virulence Drugs Against Resistant Bacterial Pathogens.
Frontiers in Microbiology,
13,
831037.
*
Artículo
7 - Feliciano,O., Falcon,R., Duquesne,A., Fleitas,O., Almaguer,T., Gutierrez,O., Orellana,A., Capo,V., Llanes,R. (2020). Helicobacter pylori antigen recognition patterns among cuban patients using Helicoblot 2.1 diagnostic system.
Tropical Gastroenterology,
40 (3),
93-98.
*
Revisión
8 - Martinez,O.F., Cardoso,M.H., Ribeiro,S.M., Franco,O.L. (2019). Recent Advances in Anti-virulence Therapeutic Strategies With a Focus on Dismantling Bacterial Membrane Microdomains, Toxin Neutralization, Quorum-Sensing Interference and Biofilm Inhibition.
Frontiers in Cellular and Infection Microbiology,
9.
*
Revisión
9 - Martinez,O.F., Rigueiras,P.O., Pires,A.D., Porto,W.F., Silva,O.N., de la Fuente-Nunez,C., Franco,O.L. (2019). Interference With Quorum-Sensing Signal Biosynthesis as a Promising Therapeutic Strategy Against Multidrug-Resistant Pathogens.
Frontiers in Cellular and Infection Microbiology,
8.
*
Artículo
10 - Feliciano-Sarmiento,O., Fleitas-Martinez,O., Falcon-Marquez,R., Almaguer-Rodriguez,T., Torres-Rodriguez,C., Silega-Coma,G., Ramirez-Cintra,Y., Gutierrez-Gonzalez,O., Llanes-Caballero,R. (2018). Methodology to obtain and evaluate a protein extract of an autochthonous Helicobacter pylori strain.
VacciMonitor,
27 (3),
102-109.
*
Revisión
11 - Fleitas,O., Agbale,C.M., Franco,O.L. (2016). Bacterial resistance to antimicrobial peptides: an evolving phenomenon.
Frontiers in Bioscience-Landmark,
21,
1013-1038.
*
Revisión
12 - Fleitas,O., Franco,O.L. (2016). Induced Bacterial Cross-Resistance toward Host Antimicrobial Peptides: A Worrying Phenomenon.
Frontiers in Microbiology,
7,
381.
*
Revisión
13 - Martinez,O.F., Agbale,C.M., Nomiyama,F., Franco,O.L. (2016). Deciphering bioactive peptides and their action mechanisms through proteomics.
Expert Review of Proteomics,
13 (11),
1007-1016.
*
Artículo
14 - Agbale,C.M., Fleitas,O., Galyuon,I.K., Franco,O.L. (2015). Optimization of antimicrobial peptide design: insights form action mechanisms.
Postdoc journal,
3,
14-24.
*
Artículo
15 - Diaz-Garcia,A., Ruiz-Fuentes,J.L., Yglesias-Rivera,A., Rodriguez-Sanchez,H., Riquenes-Garlobo,Y., Fleitas-Martinez,O., Fraga-Castro,J.A. (2015). Enzymatic analysis of venom from Cuban scorpion Rhopalurus junceus.
Journal of Venom Research,
6,
11-18.
*
Artículo
16 - Bernardo,L., Fleitas,O., Pavon,A., Hermida,L., Guillen,G., Guzman,M.G. (2009). Antibodies Induced by Dengue Virus Type 1 and 2 Envelope Domain III Recombinant Proteins in Monkeys Neutralize Strains with Different Genotypes.
Clinical and Vaccine Immunology,
16 (12),
1829-1831.
*
Artículo
17 - de Souza,C.M., Oliveira,O.W.S., Fleitas-Martinez O., Dos Santos Neto,N.A., Buccini,D.F., Nieto-Marin,V., de Faria Junior,C., Rocha,M.M., Soller Ramada,M.H., Franco,O.L.. Evaluating virulence features of Acinetobacter baumannii resistant to polymyxin B.
Letters in Applied Microbiology,
77 (7),
ovae061.
*
Artículo
18 - Fleitas,O., Fontes,W., de Souza,C.M., Da Costa,M.C., Cardoso,M.H., Castro,M.S., Sousa,M.V., Ricart,C.A.O., Ramada,M.H.S., Duque,H.M., Porto,W.F., Silva,O.N., Franco,O.L.. A proteomic perspective on the resistance response of Klebsiella pneumoniae to antimicrobial peptide PaDBS1R1.
Journal of Antimicrobial Chemotherapy,
79 (1),
112-122.
*
Artículo
19 - de Souza,C.M., Martinez,O.F., Duque,H.M., Franco,O.L.. Expanding therapeutic potential of Bdellovibrio bacteriovorus against multidrug-resistant pathogens.
Drug Discovery Today,
28 (6),
103595.
*
Revisión
20 - de Souza,C.M., da Silva,A.P., Junior,N.G.O., Martinez,O.F., Franco,O.L.. Peptides as a therapeutic strategy against Klebsiella pneumoniae.
Trends in Pharmacological Sciences,
43 (4),
335-348.
*
Revisión
21 - de Souza,C.M., da Silva,A.P., Oliveira,N.G., Martinez,O.F., Franco,O.L.. Peptides as a therapeutic strategy against Klebsiela pneumoniae.
Trends in Pharmacological Sciences,
43 (4),
335-348.
*
Revisión
22 - Martinez,O.F., Duque,H.M., Franco,O.L.. Peptidomimetics as Potential Anti-Virulence Drugs Against Resistant Bacterial Pathogens.
Frontiers in Microbiology,
13,
831037.
*
Artículo
23 - Feliciano,O., Falcon,R., Duquesne,A., Fleitas,O., Almaguer,T., Gutierrez,O., Orellana,A., Capo,V., Llanes,R.. Helicobacter pylori antigen recognition patterns among cuban patients using Helicoblot 2.1 diagnostic system.
Tropical Gastroenterology,
40 (3),
93-98.
*
Revisión
24 - Martinez,O.F., Cardoso,M.H., Ribeiro,S.M., Franco,O.L.. Recent Advances in Anti-virulence Therapeutic Strategies With a Focus on Dismantling Bacterial Membrane Microdomains, Toxin Neutralization, Quorum-Sensing Interference and Biofilm Inhibition.
Frontiers in Cellular and Infection Microbiology,
9.
*
Revisión
25 - Martinez,O.F., Rigueiras,P.O., Pires,A.D., Porto,W.F., Silva,O.N., de la Fuente-Nunez,C., Franco,O.L.. Interference With Quorum-Sensing Signal Biosynthesis as a Promising Therapeutic Strategy Against Multidrug-Resistant Pathogens.
Frontiers in Cellular and Infection Microbiology,
8.
*
Artículo
26 - Feliciano-Sarmiento,O., Fleitas-Martinez,O., Falcon-Marquez,R., Almaguer-Rodriguez,T., Torres-Rodriguez,C., Silega-Coma,G., Ramirez-Cintra,Y., Gutierrez-Gonzalez,O., Llanes-Caballero,R.. Methodology to obtain and evaluate a protein extract of an autochthonous Helicobacter pylori strain.
VacciMonitor,
27 (3),
102-109.
*
Revisión
27 - Fleitas,O., Agbale,C.M., Franco,O.L.. Bacterial resistance to antimicrobial peptides: an evolving phenomenon.
Frontiers in Bioscience-Landmark,
21,
1013-1038.
*
Revisión
28 - Fleitas,O., Franco,O.L.. Induced Bacterial Cross-Resistance toward Host Antimicrobial Peptides: A Worrying Phenomenon.
Frontiers in Microbiology,
7,
381.
*
Revisión
29 - Martinez,O.F., Agbale,C.M., Nomiyama,F., Franco,O.L.. Deciphering bioactive peptides and their action mechanisms through proteomics.
Expert Review of Proteomics,
13 (11),
1007-1016.
*
Artículo
30 - Agbale,C.M., Fleitas,O., Galyuon,I.K., Franco,O.L.. Optimization of antimicrobial peptide design: insights form action mechanisms.
Postdoc journal,
3,
14-24.
*
Artículo
31 - Diaz-Garcia,A., Ruiz-Fuentes,J.L., Yglesias-Rivera,A., Rodriguez-Sanchez,H., Riquenes-Garlobo,Y., Fleitas-Martinez,O., Fraga-Castro,J.A.. Enzymatic analysis of venom from Cuban scorpion Rhopalurus junceus.
Journal of Venom Research,
6,
11-18.
*
Artículo
32 - Bernardo,L., Fleitas,O., Pavon,A., Hermida,L., Guillen,G., Guzman,M.G.. Antibodies Induced by Dengue Virus Type 1 and 2 Envelope Domain III Recombinant Proteins in Monkeys Neutralize Strains with Different Genotypes.
Clinical and Vaccine Immunology,
16 (12),
1829-1831.
*